COVID-19 Prompts OTC Sales Restrictions Across Europe
Executive Summary
Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.
You may also be interested in...
Learn From Regulatory Innovation During COVID-19, Urges Global Self-Care Industry
The Global Self-Care Federation has published three papers outlining how regulatory flexibility and innovation seen during the cornavirus pandemic can be brought forward to a post-pandemic consmer heathcare sector.
2020 In Review: HBW Insight’s Five Key Takeaways For The European OTC Industry
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.
Lessons Learned: European Self-Care Industry Will Come Out Of Pandemic Stronger
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.